WHO ICTRP trial
Blood-stasis syndrome related mRNA-miRNA-lncRNA network construction and…
ChiCTR-BOC-16009239 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-BOC-16009239 |
|---|---|
| Public title | Blood-stasis syndrome related mRNA-miRNA-lncRNA network construction and biomarker identification |
| Scientific title | Blood-stasis syndrome related mRNA-miRNA-lncRNA network construction and biomarker identification |
| Primary sponsor | Guang'anmen Hospital, China Academy of Chinese Medical Sciences |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Basic science |
| Phase | Other |
| Countries | China |
| Conditions | Coronary heart disease, stroke |
| Interventions | Blood-stasis group:none;Non-blood-stasis group:none;Normal group:none |
| Registration date | Sep 21, 2016 |
| Target size | Blood-stasis group:90;Non-blood-stasis group:90;Normal group:20 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: